# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Leukemia, B-cell, chronic

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 255 results.
Understanding Chronic Lymphocytic Leukemia
Status: Recruiting
Last Changed: Jul 22, 2019
First Received: Jul 22, 2019
Disease(s): Chronic Lymphocytic Leukemia
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
Status: Recruiting
Last Changed: Apr 05, 2019
First Received: Dec 09, 2009
Disease(s): Chronic Lymphocytic Leukemia
Locations: Feinstein Institute for Medical Research, Manhasset, New York, United States
Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients
Status: Recruiting
Last Changed: Jan 22, 2020
First Received: Jul 05, 2019
Disease(s): Chronic Lymphocytic Leukemia
Intervention(s): Acalabrutinib
Locations: Research Site, Chandler, Arizona, United States
Research Site, Long Beach, California, United States
Research Site, Redlands, California, United States
Research Site, Whittier, California, United States
Research Site, Hartford, Connecticut, United States
... and 142 other locations.
Chronic Lymphocytic Leukemia Responds to Dermal Chelation
Status: Not yet recruiting
Last Changed: Apr 12, 2018
First Received: Apr 12, 2018
Disease(s): Chronic Lymphocytic Leukemia
Intervention(s): Dermal Chelation, Nutritional Therapy
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib
Status: Not yet recruiting
Last Changed: Oct 23, 2018
First Received: May 18, 2018
Disease(s): Chronic Lymphoid Leukemia
Intervention(s): Lamivudine, No prophylaxis
Locations: Università Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Roma, Italy
Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
Status: Not yet recruiting
Last Changed: Oct 15, 2018
First Received: Jun 04, 2018
Disease(s): Chronic Lymphocytic Leukemia
Intervention(s): idelalisib and rituximab
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
Status: Recruiting
Last Changed: Dec 12, 2019
First Received: Jul 11, 2016
Disease(s): Chronic Lymphocytic Leukemia
Intervention(s): Ibrutinib
Locations: Onco Ematologia Clinico Sperimentale, I.R.C.C.S. Centro di Riferimento Oncologico, Aviano, Italy
Ospedale San Raffaele, Milano, Italy
Dipartimento di Ematologia, Niguarda Cancer Center, Ospedale Niguarda, Milano, Italy
Department of Medical and Surgical Sciences, section of Hematology, Modena, Italy
Divisione di Ematologia, Universita' del Piemonte Orientale, Novara, Italy
... and 9 other locations.
Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia
Status: Recruiting
Last Changed: Feb 05, 2020
First Received: Aug 30, 2019
Disease(s): Untreated Chronic Lymphocytic Leukemia
Intervention(s): Acalabrutinib, Rituximab, Chlorambucil
Locations: Research Site, Beijing, China
Research Site, Changchun, China
Research Site, Fuzhou, China
Research Site, Guiyang, China
Research Site, Hangzhou, China
... and 30 other locations.
A Study of Clinical Outcomes in Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece
Status: Recruiting
Last Changed: Jan 23, 2020
First Received: Nov 12, 2019
Disease(s): Chronic Lymphocytic Leukemia (CLL)
Locations: Metropolitan General Hospital /ID# 212934, Cholargos, Attiki, Greece
University General Hospital of Ioannina /ID# 212936, Ioannina, Greece
Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Status: Recruiting
Last Changed: Nov 15, 2019
First Received: Aug 01, 2018
Disease(s): Chronic Lymphocytic Leukemia
Intervention(s): Bendamustine, Venetoclax, Rituximab
Locations: Columbia University Medical Center, New York, New York, United States